Zidovudine/lamivudine for HIV-1 infection contributes to limb fat loss.
Lipoatrophy is known to be associated with stavudine as part of the treatment for HIV infection, but it is less clear if this serious side effect is also related to other nucleoside reverse transcriptase inhibitors like zidovudine. We aimed to determine whether zidovudine-sparing first-line antiretr...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-05-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2682584?pdf=render |